The increase is for mostly for industrialization of research results from universities through public private partnerships. Regenerative medicine and the industrialization of iPS cell technology will be strongly supported
Nikkei Biotech, February 13, 2013
JST obtains FY2013 budget of 126 billion Yen, over 20 billion Yen increase from FY2012